How competition lowers the costs of medicines

PharmacoEconomics

Volumn 14, Issue SUPPL. 1, 1998, Pages 107-113

  Duncan Reekie, W ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG; NEW DRUG;

COMPETITION; CONFERENCE PAPER; COST CONTROL; DRUG COST; DRUG MARKETING; EUROPE; HEALTH CARE COST; HEALTH ECONOMICS; PRIORITY JOURNAL; SOUTH AFRICA; UNITED STATES;

DRUG COSTS; DRUG INDUSTRY; HUMANS;

EID: 0031874329     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199814001-00013     Document Type: Conference Paper

References (3)

1. Reekie WD. Medicine prices and innovations: an international survey. London: Institute of Economic Affairs, 1996
2. Boston Consulting Group. The changing environment for US pharmaceuticals. Boston, 1993
3. Reekie WD. Pricing new pharmaceutical products. London: Croom Helm, 1976